Member Board Of Directors @ (September 2015 - October 2017)
Global Commercial VP LYNPARZA and DDR Franchise @ (October 2017 - September 2020)
Sr. Director, Commercial Strategy @ (April 2012 - September 2013)
Pharmaceutical Sales Representative @ (December 1999 - May 2001)
Faris Refaie Education
MIT Sloan School of Management
Executive Program
2015-2015
McMaster University
Master of Business Administration (MBA) (Strategic Marketing)
1997-1999
McMaster University
Honours Bachelor of Science (Biochemistry)
1993-1997
Faris Refaie Skills
Culture & Employee engagement
Strategic thinking & Partnerships
Business Planning & Performance
Oncology and Hematologic Malignancies
Hematologic Malignancies
Employee Engagement
Business Transformation
Strategic Partnerships
Pharmaceutical Sales
Sales Effectiveness
Pharmaceutical Industry
Cardiology
Market Access
Hospital Sales
Gastroenterology
Oncology
Neurology
Diabetes
Urology
Rheumatology
Product Launch
Endocrinology
Pulmonology
Dermatology
KOL development
Osteoporosis
Nephrology
Therapeutic Areas
Strategy
Medical Affairs
Infectious Diseases
Allergy
Vaccines
Hematology
Hypertension
Team Building
Social Media
Public Speaking
Sales
Event Planning
Teaching
Advertising
Strategic Planning
Entrepreneurship
Microsoft Excel
Marketing
Event Management
Training
Time Management
Customer Service
Small Business
Public Relations
Coaching
Marketing Strategy
Faris Refaie Summary
Faris Refaie, based in Toronto, ON, CA, is currently a Chief Commercial Officer (CCO) at JAMP Pharma Group. Faris Refaie brings experience from previous roles at GSK and AstraZeneca. Faris Refaie holds a 2015 - 2015 Executive Program @ MIT Sloan School of Management. With a robust skill set that includes Culture & Employee engagement, Strategic thinking & Partnerships, Business Planning & Performance, Oncology and Hematologic Malignancies, Hematologic Malignancies and more. Faris Refaie has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Faris Refaie?
Find contact details for 700 million professionals.